GPT and metabolic dysfunction-associated steatotic liver disease: The incidence of NAFLD was notably greater among individuals with hyperuricemia in comparison to those without (33.8% vs. 14.7%). Those with hyperuricemia exhibited a higher occurrence of elevated liver enzymes in contrast to those without (AST 8.9% vs. 3.0%; ALT 9.6% vs. 4.7%) (52).